Found 13 matching trials
A Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-386 in Healthy Male Volunteers
PHASE1a study to investigate the pharmacokinetic characteristics and safety/toler...
Location
Gachon University Gil Medical Center
A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(5) 80/20/10mg
PHASE1A Clinical Trial to evaluate the Pharmacokinetics and Tolerability of CKD-3...
Location
H plus Yangji hospital
A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(3) 80/20/10mg
PHASE1A Clinical Trial to evaluate the Pharmacokinetics and Tolerability of CKD-3...
Location
H plus Yangji hospital
Clinical Trial to Evaluate the Efficacy and Safety of CKD-386
PHASE3Clinical Trial to Evaluate the Efficacy and Safety of CKD-386...
Location
Yonsei University Medical Center Severance Hospital
A Study to Investigate Drug Interaction Between D326, D337, and D013 in Healthy Male Subjects
PHASE1A study to investigate drug interaction between D326, D337, and D013 in hea...
Location
Korea University Anam Hospital
Clinical Study to Evaluate the Efficacy and Safety of CKD-348(CKD-828, D326, D337) Tablet
PHASE3to evaluate the efficacy and safety of CKD-828, D326, and D337 combination ...
Location
Korea University Guro Hospital
A Study to Investigate Drug-Drug Interaction Between D326, D337 and CKD-828 in Healthy Subjects
PHASE1To evaluate pharmacokinetic properties and drug interactions between D326 a...
Location
Asan Medical Center, University of Ulsan
A Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-386 in Healthy Adult Volunteers
PHASE1The purpose of this study is to evaluate the pharmacokinetics and Safety/To...
Location
Multiple Locations
A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2)
PHASE1A Clinical Trial to evaluate the Pharmacokinetics and Tolerability of CKD-3...
Location
H Plus Yangji Hospital
Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-386 in Healthy Volunteers Under Fasting Conditions
PHASE1This study is a randomized, open-label, single dose, crossover study to eva...
Location
H+ Yangji Hospita